News from the healthcare data industry
June 17, 2022 – As efforts to reduce and eventually eliminate cancer, such as President Biden’s Cancer Moonshot, gain traction, providers are tasked with finding ways to improve cancer care delivery and research....
Lynx and Clalit will work together to facilitate medical research, development, and new opportunities for healthcare data innovation PALO ALTO, Calif., June 16, 2022 /PRNewswire/ — Lynx MD and Clalit Health Services, the largest provider...
In a retrospective cohort study reported in JAMA Network Open, Sanjay Popat, FRCP, PhD, and colleagues found that among patients initiating first-line pembrolizumab for EGFR and ALK wild-type advanced non–small cell lung cancer (NSCLC), ever-smokers had...
Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with Intermountain Healthcare, a Utah-based, nonprofit healthcare system, which leverages genomic testing and data analytics to advance...
By Jim Robbins In December 2021, the FDA issued draft guidance to lifescience researchers on evaluating EHR and claims data in studies to support regulatory decisions. This new draft guidance covers...
BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world’s largest collection of clinical data FRANKLIN LAKES, N.J., June 13, 2022 /PRNewswire/ — BD...
The bipartisan bill would reform the FDA pathway that provides early access to treatments for patients with serious and life-threatening conditions Washington, D.C.—U.S. Senators Susan Collins (R-ME) and Tim Kaine...
June 15, 2022 09:15 AM Eastern Daylight Time ST. LOUIS–(BUSINESS WIRE)–Pierian®, a global leader in advanced clinical genomics technology and services, announced with Syapse®, a leading real-world evidence company, a new joint...
Boston, MA, June 15, 2022 –(PR.com)– PharmStars, the pharma-focused accelerator for digital health startups, is pleased to announce that it is now accepting applications for its Fall 2022 cohort with the...
Relative to white patients, racial and ethnic groups saw a sharper decline in access to medicines to treat opioid use disorder during the early stages of the COVID-19 pandemic—intensifying pre-pandemic...